Perimenopausal depression

American Journal of Psychiatry

Volumn 165, Issue 1, 2008, Pages 23-27

  Parry, Barbara L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT; CLONIDINE; CONJUGATED ESTROGEN; ESTROGEN; ETHINYLESTRADIOL; FLUOXETINE; GABAPENTIN; GESTAGEN; HYPERICUM PERFORATUM EXTRACT; IMIPRAMINE; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGITATION; ANAMNESIS; ANORGASMIA; ANXIETY DISORDER; CASE REPORT; CLIMACTERIUM; DEPERSONALIZATION; DISEASE COURSE; DRUG DOSE INCREASE; FEMALE; FLUSHING; HEADACHE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HYPOTENSION; INSOMNIA; LETHARGY; MAJOR DEPRESSION; MENSTRUAL CYCLE; MONOTHERAPY; MOOD CHANGE; MOOD DISORDER; PARANOIA; PRIORITY JOURNAL; PSYCHOSIS; PUERPERAL DEPRESSION; REVIEW; SIDE EFFECT; SOMATIC DELUSION; SWEATING; TREMOR; COMORBIDITY; COMPARATIVE STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFECT; ESTROGEN THERAPY; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NOMENCLATURE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSION, POSTPARTUM; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ESTROGEN REPLACEMENT THERAPY; ETHINYL ESTRADIOL; FEMALE; FLUOXETINE; HUMANS; IMIPRAMINE; MIDDLE AGED; PERIMENOPAUSE; PROGESTERONE; PSYCHIATRIC STATUS RATING SCALES; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME;

EID: 39049090439     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.07071152     Document Type: Review

References (28)

1. Weissman MM: The myth of involutional melancholia. JAMA 1979; 242:742-744
2. Schmidt PJ, Haq N, Rubinow DR: A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry 2004; 161:2238-2244
3. Freeman EW, Sammel MD, Lin H, Nelson DB: Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006; 63:375-382
4. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL: Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006; 63:385-390
5. Ayubi-Moak I, Parry BL: Psychiatric aspects of menopause, in Women's Mental Health: A Comprehensive Textbook. Edited by Kornstein SG, Clayton AH. New York, Guilford, 2002, pp 132-143
6. Tam LW, Stucky V, Hanson RE, Parry BL: Prevalence of depression in menopause: a pilot study. Arch Womens Ment Health 1999; 2:175-181
7. Parry BL, Martinez LF, Maurer EL, Lopez AM, Sorenson DL, Meliska CJ: Sleep, rhythms, and women's mood, part 2: menopause. Sleep Med Rev 2006; 10:197-208
8. Parry BL: Sleep disturbances at menopause are related to sleep disorders and anxiety symptoms. Menopause 2007 (in press)
9. Avis NE, Brambilla D, McKinlay SM, Vass K: A longitudinal analysis of the association between menopause and depression: results from the Massachusetts Women's Health Study. Ann Epidemiol 1994; 4:214-220
10. Stewart DE, Boydell KM: Psychologic distress during menopause: associations across the reproductive life cycle. Int J Psychiatry Med 1993; 23:157-162
11. Freeman EW, Sammel MD, Rinaudo PJ, Sheng L: Premenstrual syndrome as a predictor of menopausal symptoms. Obstet Gynecol 2004; 103(5 pt 1):960-966
12. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L: Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004; 61:62-70
13. Woods NF, Mitchell ES: Patterns of depressed mood in midlife women: observations from the Seattle Midlife Women's Health Study. Res Nurs Health 1996; 19:111-123
14. Parry BL, Meliska CJ, Martinez LF, Basavaraj N, Zirpoli GG, Sorenson D, Maurer EL, Lopez A, Markova K, Gamst A, Wolfson T, Hauger R, Kripke DF: Menopause: neuroendocrine changes and hormone replacement therapy. J Am Med Womens Assoc 2004; 59:135-145
15. Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS: Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial: Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry 1997; 5:97-106
16. Tam LW, Parry BL: Does estrogen enhance the antidepressant effects of fluoxetine? J Affect Disord 2003; 77:87-92
17. Stahl SM: Basic psychopharmacology of antidepressants, part 2: estrogen as an adjunct to antidepressant treatment. J Clin Psychiatry 1998; 59(suppl 4):15-24
18. Zohar J, Shapira B, Oppenheim G, Ayd FJ, Belmaker RH: Addition of estrogen to imipramine in female-resistant depressives. Psychopharmacol Bull 1985; 21:705-706
19. Oppenheim G: A case of rapid mood cycling with estrogen: implications for therapy. J Clin Psychiatry 1984; 45:34-35
20. Chouinard G, Steinberg S, Steiner W: Estrogen-progesterone combination: another mood stabilizer? (letter). Am J Psychiatry 1987; 144:826
21. Sloan DM, Kornstein SG: Gender differences in depression and response to antidepressant treatment. Psychiatr Clin North Am 2003; 26:581-594
22. Sherwin BB: The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991; 72:336-343
23. Pinkerton JV, Pastore LM: Perspective on menopausal vasomotor symptoms, CAM, and the SWAN. Menopause 2007; 14:601-605
24. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333
25. Turgeon JL, McDonnell DP, Martin KA, Wise PM: Hormone therapy: physiological complexity belies therapeutic simplicity. Science 2004; 304:1269-1273
26. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML: Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297:1465-1477
27. Ettinger B, Barrett-Connor E, Hoq LA, Vader JP, Dubois RW: When is it appropriate to prescribe postmenopausal hormone therapy? Menopause 2006; 13:404-410
28. Geller SE, Studee L: Botanical and dietary supplements for mood and anxiety in menopausal women. Menopause 2007; 14(3, pt 1):541-549